首页> 外文期刊>Pediatric Surgery International >The treatment of internal anal sphincter achalasia with botulinum toxin
【24h】

The treatment of internal anal sphincter achalasia with botulinum toxin

机译:肉毒杆菌毒素治疗肛门内括约肌失弛缓症

获取原文
获取原文并翻译 | 示例
           

摘要

Internal anal sphincter (IAS) achalasia is a disorder of defecation in which the IAS fails to relax. Botulinum toxin (BT), which has been successfully used to relax the anal and lower esophageal sphincters, was injected twice into the IAS of one adolescent and three infants with manometric, radiologic, and in 2 cases histochemical diagnosis of anal achalasia; in the adolescent a third injection was necessary. Spontaneous defecation was achieved in all patients following the second injection. In one case a diagnosis of short-segment Hirschsprung's disease was obtained after the second injection. Local infiltration of BT into the IAS proved effective in the treatment of IAS achalasia. Double-blind studies and longer follow-up periods are needed to better evaluate these preliminary results and define the limits of this promising therapy.
机译:肛门内括约肌(IAS)失弛缓症是一种排便障碍,IAS无法放松。已成功将肉毒杆菌毒素(BT)成功用于缓解肛门和食管下括约肌括约肌,已向一名青春期和三名具有测压,放射学和2例经肛门组织化学性诊断的婴儿的IAS中注射了两次;在青少年时期,有必要进行第三次注射。第二次注射后所有患者均自发排便。在一种情况下,第二次注射后可诊断为短节段性巨结肠症。 BT在IAS中的局部浸润被证明可有效治疗IAS asia门失弛缓症。为了更好地评估这些初步结果并确定这种有希望的治疗方法的局限性,需要进行双盲研究和更长的随访时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号